Login

Nicorette Fruit 4 mg Lozenge

*
General Sale: Non-prescription

  • Company:

    Kenvue

  • Status:

    No Recent Update

  • Legal Category:

    Supply through general sale

  • Active Ingredient(s):

    Nicotine Resinate

    *Additional information is available within the SPC or upon request to the company

Updated on 26 June 2024

File name

ie-spc-v10-nicorette-fruit-loz-4mg-2456.pdf

Reasons for updating

  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 10 - Date of revision of the text

Legal category:Supply through general sale

Updated on 14 March 2024

File name

ie-leaflet-mock-up-nic-fruit-2mg4mg-2436.pdf

Reasons for updating

  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision

Updated on 14 March 2024

File name

ie-spc-v9-nic-fruit-loz-4mg-2436.pdf

Reasons for updating

  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text

Legal category:Supply through general sale

Updated on 24 January 2024

File name

ie-leaflet-nicorette-fruit-lozenge-2mg-4mg-2506.pdf

Reasons for updating

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Updated on 24 January 2024

File name

ie-pl-nic-cools-2mg4mg-2497.pdf

Reasons for updating

  • Change to name of medicinal product

Updated on 03 January 2024

File name

ie-leaflet-nicorette-fruit-lozenge-2mg-4mg-2506.pdf

Reasons for updating

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Updated on 03 January 2024

File name

ie-spc-v8-nic-fruit-loz-4mg-2506.pdf

Reasons for updating

  • Change to section 7 - Marketing authorisation holder
  • Change to section 10 - Date of revision of the text

Legal category:Supply through general sale

Updated on 14 August 2023

File name

ie-pl-nic-fruit-loz-2mg4mg-2266.pdf

Reasons for updating

  • Change to section 2 - what you need to know - contraindications
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 14 August 2023

File name

ie-spc-v7-nic-fruit-loz-4mg-2266.pdf

Reasons for updating

  • Change to section 4.3 - Contraindications
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text

Legal category:Supply through general sale

Updated on 25 February 2023

File name

ie-spc v6-nicorette-fruit-loz-4mg-2267.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 10 - Date of revision of the text

Legal category:Supply through general sale

Updated on 25 February 2023

File name

ie-pl-nicorette-fruit-loz-2267.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - date of revision

Updated on 06 January 2022

File name

ie-spc v5 nicorette fruit 4mg lozenge - 2178 (1).pdf

Reasons for updating

  • Improved presentation of SPC

Legal category:Supply through general sale

Updated on 28 January 2021

File name

ie-mockup-pl-fruit-4mg-clean-bv2087.pdf

Reasons for updating

  • Change to section 3 - dose and frequency
  • Change to section 4 - how to report a side effect
  • Change to section 6 - what the product contains
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision

Updated on 28 January 2021

File name

ie-spc-clean-pa-330-37-18-bv2087.pdf

Reasons for updating

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to Section 4.8 – Undesirable effects - how to report a side effect
  • Change to section 6.1 - List of excipients
  • Change to section 10 - Date of revision of the text

Legal category:Supply through general sale

Updated on 04 December 2019

File name

nicorette-fruit-4mg-spc-clean-bv1905.pdf

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 10 - Date of revision of the text

Legal category:Supply through general sale

Updated on 04 December 2019

File name

ie-pl-fruit-2mg4mg.pdf

Reasons for updating

  • Change to section 1 - what the product is used for
  • Change to section 2 - driving and using machines
  • Change to section 3 - use in children/adolescents
  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects
  • Change to section 5 - how to store or dispose
  • Change to section 6 - date of revision

Updated on 17 June 2019

File name

NCQ02 BV 1813 SPC .pdf

Reasons for updating

  • File format updated to PDF

Legal category:Supply through general sale

Updated on 05 June 2018

File name

NCQ02 BV 1813 SPC .docx

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text

Legal category:Supply through general sale

Updated on 21 May 2018

File name

ie-mockup-leaflet.pdf

Reasons for updating

  • New PIL for new product

Updated on 07 February 2018

Reasons for updating

  • New SPC for new product

Legal category:Supply through general sale